← CardioNews 列表 | 心血管·血管外科
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter ...
M-TEER with the fourth-generation M-TEER device was safe and effective at 1 year, with durable reductions in MR severity to ≤1+ in more than 90% of patients.
🔗 阅读原文 ↗